[Pharm-policy] JEC study on NIH role in medical research

[James Love]

Tate has kindly provided a pointer to a nw, May 17, 2000 study:

  The Benefits of Medical Research and the Role of NIH.

The report was repared by the Joint Economic Committee, apparently
at the Request of Senator Connie Mack of Florida.  The full report is on
the Internet here:
 
   http://www.senate.gov/~jec/nih.pdf

Here is just one of many interesting quotes:

"A study of the 21 drugs introduced between 1965 and 1992 that were
considered by experts to have had the highest therapeutic impact on
society found that public funding of research was instrumental in the
development of 15 of the 21 drugs (71 percent). Three-captopril
(Capoten), fluoxetine (Prozac), and acyclovir (Zovirax)-had more than $1
billion in sales in 1994 and 1995. In addition to these drugs, other
members of the group of 21 drugs, including AZT, acyclovir, fluconazole
(Diflucan), foscarnet (Foscavir), and ketoconazole (Nizoral), had NIH
funding and research to help in clinical trials.62 "

 

=======================================================
James Love, Director           | http://www.cptech.org
Consumer Project on Technology | mailto:love@cptech.org 
P.O. Box 19367                 | voice: 1.202.387.8030
Washington, DC 20036           | fax:   1.202.234.5176
=======================================================